Irene De Biase, MD, PhD

Languages spoken: English, Italian

Departments Primary - Pathology

Education History

Fellowship	Greenwood Genetic Center	Fellow
Postdoctoral Fellowship	University of Oklahoma Health Sciences Center, Department of Biochemistry and Molecular Biology	Postdoctoral Fellow
Doctoral Training	Federico II University	PhD
Professional Medical	Federico II University	MD

Prinzi J, Pasquali M, Hobert JA, Palmquist R, Wong KN, Francis S, De Biase I (2023). Diagnosing X-Linked Adrenoleukodystrophy after Implementation of Newborn Screening: A Reference Laboratory Perspective. Int J Neonatal Screen, 9(4). (Read full article)
Yuzyuk T, McDonald CM, Zuromski LM, De Biase I, Johnson L, Williams N, Meihls S, Asfour F (2023). Improvement of lipid and lipoprotein profiles in children and adolescents with cystic fibrosis on CFTR modulator therapy. J Cyst Fibros. (Read full article)
De Biase I, Yuzyuk T, Cui W, Zuromski LM, Moser AB, Braverman NE (2023). Quantitative analysis of ethanolamine plasmalogen species in red blood cells using liquid chromatography tandem mass spectrometry for diagnosing peroxisome biogenesis disorders. Clin Chim Acta, 542, 117295. (Read full article)

De Biase I, de Dios K, Brose SA, Hobert JA (2024). Autism Spectrum Disorder and Mild Developmental Delay in a Patient with a Rare Inborn Error of Metabolism. Clin Chem, 70(6), 882-884. (Read full article)

Nelson HA, De Biase I, Balogun K, McDonald CM, Meihls S, Asfour F, Yuzyuk T (2023). CFTR Modulator Therapy Increases Plasma Concentrations of Vitamin A in Patients with Cystic Fibrosis [Abstract]. 69(1, Supplement), A-340.